QuantumPharm Inc. Global Offering prospectus
Hong Kong prospectus dated 4 June 2024. The allotment results announcement refers to "the prospectus dated June 4, 2024"; HKEXnews lists the PDF on 04/06/2024.
- Issued by
- No issuing record yet. A missing record is a gap in coverage.
- Authors credited
- No authorship claim recorded yet. The source record lists QuantumPharm Inc. (now XtalPi Holdings Limited), published on HKEXnews.
- Dates
- No date claim recorded yet. The source record gives the publication date as 2024-06-04.
- Exact source
- QuantumPharm Inc. Global Offering (Hong Kong prospectus) QuantumPharm Inc. (now XtalPi Holdings Limited), published on HKEXnews · published 2024-06-04 · Retrieved for the candidate pack on 2026-10-30 (SHA-256 fce5a6aee28817f6b479cf259cfe75d65f48b1519f6173f21cf183bb767a93df). HKEXnews PDF 2024060400065, English prospectus dated June 4, 2024, as served on 2026-10-30.
Appears in
No collection holds a record about this document yet.
Versions
No other versions of this document are recorded. The evidence applies to the source version listed above. Other versions, such as a preprint, working paper or journal publication, are not identified or substituted.
Documentary relations
Each relation is listed separately. Citing, crediting and reporting the use of a method are different acts, and none of them shows agreement or influence by itself.
Not recorded for this document: cites · cited by · explicitly credits · reports using a method from · method reported as used by · applies parts of · parts applied by · discusses · reports evaluation of. A missing record does not show that the relation does not exist.
What the document states
A limited selection of what this document states, each with its passage. It describes the text, not whether anyone acted on it.
- Statementlisting basis: Specialist Technology Company and Pre-Commercial Company under Chapter 18C of the Listing Rules“Our Company is a Specialist Technology Company (as defined in Chapter 18C of the Listing Rules).”Cover pages (PDF p. 2)Inspect claim & evidence ↗
- Statementcompany account: 2016 Pfizer crystal structure prediction blind test led to a long-term strategic partnership with Pfizer“In 2016, we participated in a global crystal structure prediction (“CSP”) blind test held by Pfizer and achieved accurate prediction, which led to our long-term strategic master partnership in technological innovation and drug R&D with Pfizer.”Summary, "Overview" (PDF p. 10)Inspect claim & evidence ↗
- Statementself-description: "a quantum physics-based, AI-powered, and robotics-driven, innovative R&D platform"“We are a quantum physics-based, AI-powered, and robotics-driven, innovative R&D platform.”Summary, "Overview" (PDF p. 10)Inspect claim & evidence ↗